Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia
Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia
Not yet recruiting · NCT07816341 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia | Hemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorder | Not yet recruiting | Phase 1 | 2026-09-11 | NCT07816341 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Red Blood Cell Diseases Center and Regenerative Medicine Center | Tianjin | China | 3 |